1887

Journal of Medical Microbiology logo

Volume 24, Issue 4

Response of to antibiotics, bismuth and an acid-reducing agent –an ultrastructural study Free

Abstract

Summary

was cultured for maximal growth in liquid medium, and effects of exposure to various -lactam and macrolide antibiotics, metronidazole, tripotassium dicitrato bismuthate (TDB) and cimetidine were monitored by transmission electronmicroscopy after periods of exposure up to 24 h. With amoxycillin and benzylpenicillin (0·12–1 mg/L) and cephalexin (2 mg/L) the normal bacilliform morphology was replaced by bulging and dumb-bell-like profiles showing cell-wall blebbing and vesiculation, and eventually by swollen forms with incomplete cell walls undergoing lysis. These changes developed progressively between 2h and 24 h and were accelerated at the higher antibiotic concentrations. Erythromycin and clindamycin caused central clearing, ribosomal coagulation and impaired cross-wall formation. There were no gross structural changes in the presence of metronidazole (4 mg/L), TDB (1000 and 2400 mg/L) or cimetidine (1000 and 2000 mg/L); but with TDB focal accumulation of particulate bismuth complex was detected under the cell wall, affecting nearly all organisms by 24 h. In parallel viability tests, metronidazole and TDB both showed bactericidal activity, but cimetidine did not. These findings support the clinical experience that favours combination therapy with bismuth plus an appropriate systemic antibiotic as the regimen of choice for effective clearance of the organisms in . -associated gastritis.

  • Received:
  • Accepted:
  • Published Online:
© 1987 Pathological Society of Great Britain and Ireland
Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-24-4-343
1987-12-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/24/4/medmicro-24-4-343.html?itemId=/content/journal/jmm/10.1099/00222615-24-4-343&mimeType=html&fmt=ahah

References

  1. Axon A T R. 1986; Campylobacterpyloridis: what role in gastritis and peptic ulcer?. British Medical Journal 293:772–773
     [Google Scholar]
  2. Bardhan K D, Cole D S, Hawkins B W, Franks C R. 1982; Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?. British Medical Journal 284:621–623
     [Google Scholar]
  3. Coghill S B, Hopwood D, McPherson S, Hislop S. 1983; The ultrastructural localisation of De-Nol (colloidal tripotas-sium dicitrato-bismuthate-TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administration. Journal of Pathology 139:105–114
     [Google Scholar]
  4. Czinn S, Carr H, Aronof T S. 1986; Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin. Antimicrobial Agents and Chemotherapy 30:328–329
     [Google Scholar]
  5. Elliott T S J, Greenwood D. 1983; The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin. Journal of Medical Microbiology 16:351–362
     [Google Scholar]
  6. Elliott T S J, Greenwood D. 1984; The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. Journal of Medical Microbiology 17:159–169
     [Google Scholar]
  7. Florey H W. 1949; Antibiotics. II Oxford University Press; London:1144–1156
     [Google Scholar]
  8. Gardner A D. 1940; Morphological effects of penicillin on bacteria. Nature 146:837–838
     [Google Scholar]
  9. Goodwin C S, McCulloch R K, Armstrong J A, Wee S H. 1985a; Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. Journal of Medical Microbiology 19:257–267
     [Google Scholar]
  10. Goodwin C S, Blake P, Blincow E. 1986; The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis . Journal of Antimicrobial Chemotherapy 17:309–314
     [Google Scholar]
  11. Goodwin C S, Armstrong J A, Marshall B J. 1986b; Campylobacter pyloridis, gastritis, and peptic ulceration. Journal of Clinical Pathology 39:353–365
     [Google Scholar]
  12. Hazell S L, Lee A. 1985; The adaptation of motile strains of Campylobacter pyloridis to gastric mucus and their association with gastric epithelial intercellular spaces. Pearson A D. Campylobacter IIIProceedings of the third international workshop on campylobacter infections. Public Health Laboratory ServiceLondon189–191
     [Google Scholar]
  13. Langenberg M L. 1985; The pathogenic role of Campylobacter pyloridis studied by attempts to eliminate these organisms. Pearson A D. Campylobacter III: Proceedings of the third international workshop on campylobacter infections. Public Health Laboratory ServiceLondon162–163
     [Google Scholar]
  14. Marshall B J, Warren J R. 1984; Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1314
     [Google Scholar]
  15. Marshall B J. 1984; Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Letters 25:83–88
     [Google Scholar]
  16. Marshall B J, McGechie D B, Rogers P A, Glancy R J. 1985a; Pyloric campylobacter infection and gastroduodenal disease. Medical Journal of Australia 142:439–444
     [Google Scholar]
  17. Marshall B J, McGechie D B, Armstrong J A, Francis G. 1985b; The antibacterial action of bismuth: early results of antibacterial regimens in the treatment of duodenal ulcer. Pearson A D. Campylobacter III: Proceedings of the third international workshop on campylobacter infections. Public Health Laboratory ServiceLondon165–166
     [Google Scholar]
  18. Marshall B J, Armstrong J A, Francis G J, Nokes N T, Wee S H. The antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion (in press)
     [Google Scholar]
  19. McNulty C A M, Dent J, Wise R. 1985; Susceptibility of clinical isolates of Campylobacter pyloridis to eleven antimicrobial agents. Antimicrobial Agents and Chemotherapy 28:837–838
     [Google Scholar]
  20. Nishino T, Nakazawa S. 1972; Morphological changes in Staphylococcus aureus and Escherichia coli exposed to cephalexin. Japan Journal of Microbiology 16:83–94
     [Google Scholar]
  21. Reynolds E S. 1963; The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. Journal of Cell Biology 17:208–213
     [Google Scholar]
  22. Rolinson G N, Macdonald A C, Wilson D A. 1977; Bactericidal action of beta-lactam antibiotics on Escherichia coli with particular reference to ampicillin and amoxycillin. Journal of Antimicrobial Chemotherapy 3:541–543
     [Google Scholar]
  23. Tricottet V. 1986; Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastructural Pathology 10:113–122
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-24-4-343
Loading
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro–an ultrastructural study
J. Med. Microbiol. 24, 343 (1987); https://doi.org/10.1099/00222615-24-4-343
/content/journal/jmm/10.1099/00222615-24-4-343
/content/journal/jmm/10.1099/00222615-24-4-343
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error